
Research News
-
RD Fund Invests in Perceive Pharma for Development of Neuroprotective Therapies
Perceive Pharma is a spin out of Perceive Biotherapeutics.
-
Leber Congenital Amaurosis Research Advances
Recent developments in research on Leber congenital amaurosis
-
Age-Related Macular Degeneration Research Advances
Recent developments in research on age-related macular degeneration.
-
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmentosa.
-
Stargardt Disease Research Advances
Recent developments in research on Stargardt disease
-
Atsena to Launch Part B of Phase 1/2 Clinical Trial for XLRS Gene Therapy
The Foundation is a founding investor in Atsena.
-
The company is also planning to conduct the clinical trial at sites in the EU.
-
The company has also launched a natural history study of patients to inform the planned clinical trial.
-
Sepul Bio Launches Phase 2b Clinical Trial for USH2A RNA Therapy
Known as ultevursen, the USH2A RNA therapy was licensed from ProQR.